Richard J Stark

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. ncbi Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks
    R Stark
    Alfred Hospital, Prahran, Australia
    Cephalalgia 22:23-32. 2002
  2. ncbi Management of migraine in Australian general practice
    Richard J Stark
    Neurology Department, Alfred Hospital, Melbourne, Vic, Australia
    Med J Aust 187:142-6. 2007
  3. ncbi Migraine prophylaxis
    Richard J Stark
    Alfred Hospital, Monash University, Melbourne, Vic, Australia
    Med J Aust 189:283-8. 2008

Collaborators

Detail Information

Publications3

  1. ncbi Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks
    R Stark
    Alfred Hospital, Prahran, Australia
    Cephalalgia 22:23-32. 2002
    ..01). Adverse events for all treatments were generally mild or moderate and self-limiting. Eletriptan 40 mg and eletriptan 80 mg both appear to be effective and well-tolerated acute migraine treatments...
  2. ncbi Management of migraine in Australian general practice
    Richard J Stark
    Neurology Department, Alfred Hospital, Melbourne, Vic, Australia
    Med J Aust 187:142-6. 2007
    ..To determine the proportion of patients who have a diagnosis of migraine in a sample of Australian general practice patients, and to review the prophylactic and acute drug treatments used by these patients...
  3. ncbi Migraine prophylaxis
    Richard J Stark
    Alfred Hospital, Monash University, Melbourne, Vic, Australia
    Med J Aust 189:283-8. 2008
    ..New strategies to aid in medication withdrawal are reviewed. The approach to menstrual migraine and migraine with prominent aura may differ from that for typical migraine. Novel approaches are being explored for these problems...